News
News
PublISHED ON
UpDATED ON
A further 8 million SEK to support clinical studies relating to COVID-19
The six regional nodes within Clinical Studies Sweden will receive an additional 8 million SEK in total, or 1.3 million SEK each, to further expand their abilities to support clinical studies linked to COVID-19.
Earlier this year, the regional nodes within Clinical Studies Sweden received a total of 12 million SEK from the Swedish Research Council. Now they will receive a further 8 million SEK to support clinical studies linked to COVID-19.
The initiative follows from the Swedish Research Council’s mandate to temporarily reinforce the activities within Clinical Studies Sweden to increase the opportunities for clinical researchers in Sweden to conduct clinical studies linked to the disease COVID-19. The funding is part of the 100 million SEK that the Swedish Research Council, in collaboration with Vinnova, has to allocate to research and innovation that can contribute to stopping the spread of COVID-19 and preventing future pandemic outbreaks.
The regional nodes offer various types of support to researchers in their work on clinical studies. Examples include help with study protocols, permit applications, data management and education.
Read more about the nodes on kliniskastudier.se
External link.
Government mandate relating to clinical studies and COVID-19
Mandate to temporarily reinforce the activities within Clinical Studies Sweden External link.(in Swedish)
MORE WITHIN THE SAME SUBJECT AREA
-
Publication |
Published 27 February 2023
The Swedish Research Council’s research review in clinical thearpy research describes the current situation for the research and makes a forecast of the development during the next 5–10 years. The review also includes scientific and research policy r...
-
Article |
Published 25 January 2023
You will receive an automated email from Prisma once the reporting period has started.
-
News |
Published 12 April 2022
Increased knowledge, national coordination and regular mappings of unclear areas and obstacles. This is the way forward for improving the utilisation of health data for research and innovation. We are now beginning the work of establishing national s...